MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health Current Ratio 2011-2026 | OPK
Annual Current Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.64 | 3.23 | 3.58 | 3.36 | 3.09 | 1.3 | 1.1 | 1.14 | 1.84 | 1.8 | 1.72 | 2.64 | 1.5 | 5.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.3 | 1.1 | 2.45 |
Quarterly Current Ratio OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.92 | 2.61 | 2.65 | 3.39 | 2.74 | 3.36 | 3.46 | 3.51 | 3.58 | 3.73 | - | 3.33 | 3.36 | 3.71 | 3.57 | 3.06 | 3.09 | 3.09 | 3.09 | 3.09 | 3.33 | 3.33 | 3.33 | 3.33 | 3.71 | 3.71 | 3.71 | 3.71 | 3.47 | 3.53 | 3.53 | 3.53 | 3.84 | 4.1 | 4.1 | 4.1 | 3.42 | 3.42 | 3.42 | 3.42 | 2.93 | 2.93 | 2.93 | 2.93 | 2.68 | 2.68 | 2.68 | 2.68 | 3.35 | 3.35 | 3.35 | 3.35 | 5.19 | 5.19 | 5.19 | 5.19 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.19 | 2.61 | 3.45 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
2.01 | $ 115.19 | 0.1 % | $ 35 B |  USA |
 |
BioNano Genomics
BNGO
|
2.52 | $ 1.14 | 0.44 % | $ 6.21 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
5.26 | $ 16.2 | 0.56 % | $ 174 M |  China |
 |
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 16.29 | 1.46 % | $ 868 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
6.01 | $ 1.41 | 2.92 % | $ 1.88 M | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
2.95 | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
7.05 | $ 23.05 | -0.35 % | $ 640 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 175.38 | -0.17 % | $ 8.69 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.3 | $ 498.64 | 1.04 % | $ 14.4 B | USA |
 |
Danaher Corporation
DHR
|
5.19 | $ 190.7 | 0.6 % | $ 136 B | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.47 | 2.64 % | $ 414 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 122.51 | 1.3 % | $ 19.5 B | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 7.94 | 3.19 % | $ 1.02 B | USA |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 14.95 | 3.57 % | $ 452 M | USA |
 |
Guardant Health
GH
|
0.953 | $ 78.76 | 0.2 % | $ 9.87 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
7.55 | $ 2.77 | 2.97 % | $ 89.9 K | USA |
 |
Biomerica
BMRA
|
3.23 | $ 2.07 | -3.19 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.69 | $ 28.27 | -0.12 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
2.29 | $ 107.75 | 0.88 % | $ 8.89 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 261.97 | 0.4 % | $ 21.8 B | USA |
 |
Natera
NTRA
|
2.02 | $ 199.83 | 3.52 % | $ 19.7 B | USA |
 |
Celcuity
CELC
|
1.27 | $ 118.95 | 1.55 % | $ 5.56 B | USA |
 |
Senseonics Holdings
SENS
|
1.94 | $ 6.67 | -0.15 % | $ 278 M | USA |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 80.99 | 0.5 % | $ 5.47 B | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 192.07 | 0.29 % | $ 21.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.96 | $ 52.58 | -0.1 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
2.51 | $ 9.19 | -2.46 % | $ 1.99 B | USA |
 |
ENDRA Life Sciences
NDRA
|
2.42 | $ 5.0 | 1.21 % | $ 3.94 M | USA |
 |
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | USA |